ginsenoside rg4은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

ginsenoside rg4은 임신 중 안전한가요?

No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).

ginsenoside rg4은 모유 수유 중 안전한가요?

No evidence was found that Rg4 is classified for reproductive or lactation hazard, and no studies showing transfer into milk or lactation toxicity for Rg4 were identified. By the priority rules, absence of CIR/SCCS/harmonised flags and lack of Rg4‑specific lactation data leads to default low hazard and mechanism scores. (Sources: PubChem/supplier pages; literature search on PubMed; EWG ingredient summary).

ginsenoside rg4은 아기 피부에 안전한가요?

No infant‑specific toxicity data for Rg4 were identified. Dermal exposure assessment: Rg4 is a large, polar glycoside (MW ~767) typical of ginsenosides; such molecules have low dermal permeability, so adult topical exposure is likely negligible (e=0). However, given immature infant barrier and instruction in scoring, exposure for baby skin is increased by +1 to e=1 in absence of infant data. No infant dermal adverse effects or studies were found. (Sources: PubChem/supplier data on structure/MW; lack of reproductive/infant studies on PubMed; EWG ingredient page).

VeriMom은 ginsenoside rg4을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 ginsenoside rg4을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 ginsenoside rg4 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.